An innovative service company focusing on the field of drug quality control
  • News

  • Company News
  • Industry information
  • Recruitment

  • Contact Us

  • News

    Contact Us

    You are here:Home >> News >> Company News

    Company News

    Today Recommend Impurities of Dapagliflozin

    Time:2022-07-22 Views:52
    Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This class of drug uses the kidneys to help control your glucose (blood sugar) levels. It works by increasing the amount of glucose removed from the body when you urinate. It was first approved by the US Food and Drug Administration (FDA) in 2014.
    The following are some of the impurities of Dapagliflozin: